RUA Life Sciences Cash Flow Statement

Financials in millions GBP. Fiscal year is October - September.

Millions GBP. Fiscal year is Oct - Sep.

Fiscal Year	FY 2025	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Net Income	-0.15	0	-1.44	-2	-2.07
Depreciation & Amortization	0.44	0.42	0.36	0.36	0.31
Other Amortization	-	-	-	-	0
Loss (Gain) From Sale of Assets	-0.6	-	-	-	-
Stock-Based Compensation	0.11	0.11	-0.04	0.1	0.15
Other Operating Activities	-0.03	-0.93	-0.5	-0.3	-0.29
Change in Accounts Receivable	0.01	0.18	-0.36	0.33	-0.05
Change in Inventory	-0.14	0	-0.03	0.04	-0.04
Change in Accounts Payable	0.12	0.01	0.1	-0.2	-0.45
Change in Income Taxes	0.09	-0.01	0.57	0.53	0.09
Operating Cash Flow	-0.13	-0.22	-1.33	-1.15	-2.35
Capital Expenditures	-0.11	-0.06	-0.06	-0.45	-0.9
Sale of Property, Plant & Equipment	0	0	0.03	-	-
Cash Acquisitions	0.07	0.1	-	-	-
Other Investing Activities	0.04	0.03	-0.06	-0.03	-0.01
Investing Cash Flow	-0	0.07	-0.09	-0.48	-0.91
Long-Term Debt Issued	-	0.03	0.01	0.23	-
Total Debt Issued	0.03	0.03	0.01	0.23	-
Long-Term Debt Repaid	-	-0.22	-0.15	-0.1	-0.07
Total Debt Repaid	-0.39	-0.22	-0.15	-0.1	-0.07
Net Debt Issued (Repaid)	-0.36	-0.2	-0.14	0.13	-0.07
Issuance of Common Stock	-	-	3.97	-	-
Other Financing Activities	0.05	-	0.05	-	-
Financing Cash Flow	-0.31	-0.2	3.89	0.13	-0.07
Foreign Exchange Rate Adjustments	-0.02	-0.02	-0.03	0.01	-
Net Cash Flow	-0.45	-0.36	2.45	-1.48	-3.33
Free Cash Flow	-0.24	-0.28	-1.38	-1.6	-3.26
Free Cash Flow Margin	-5.29%	-6.83%	-63.12%	-73.20%	-200.43%
Free Cash Flow Per Share	-0.00	-0.01	-0.04	-0.07	-0.15
Cash Interest Paid	0.05	0.05	0.06	0.03	0.01
Cash Income Tax Paid	-	0.01	-	-	-
Levered Free Cash Flow	-	-0.05	-1.25	-1.01	-2.72
Unlevered Free Cash Flow	-	-0.05	-1.2	-1	-2.71
Change in Working Capital	0.08	0.18	0.28	0.7	-0.46

Source: S&P Global Market Intelligence. Standard template. Financial Sources.